Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Specific Antigens”

322 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 322 results

Early research (Phase 1)Study completedNCT01414296
What this trial is testing

Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer

Who this might be right for
Prostate Cancer
Progenics Pharmaceuticals, Inc. 10
Not applicableStudy completedNCT00871585
What this trial is testing

Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide

Who this might be right for
Advanced Prostate Cancer
AstraZeneca 340
Testing effectiveness (Phase 2)Study completedNCT01496157
What this trial is testing

Evaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Testing effectiveness (Phase 2)Ended earlyNCT05489991
What this trial is testing

TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Tceleron Therapeutics, Inc. 1
Early research (Phase 1)UnknownNCT03780075
What this trial is testing

Lu177-EB-PSMA617 Radionuclide Treatment in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Peking Union Medical College Hospital 50
Large-scale testing (Phase 3)Ended earlyNCT03535675
What this trial is testing

Muscadine Plus (MPX) In Men With Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 59
Large-scale testing (Phase 3)Study completedNCT00193856
What this trial is testing

RADAR Trial - Randomised Androgen Deprivation and Radiotherapy

Who this might be right for
Prostate Cancer
Trans Tasman Radiation Oncology Group 1,071
Not applicableUnknownNCT04317625
What this trial is testing

Screening for Prostate Cancer Among Those Prostate-specific Antigen Value Between 2.5 and 4.0 ng/mL

Who this might be right for
Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 232
Large-scale testing (Phase 3)Looking for participantsNCT05939414
What this trial is testing

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Who this might be right for
Oligometastatic Prostate Cancer (OMPC)
Novartis Pharmaceuticals 450
Testing effectiveness (Phase 2)Active Not RecruitingNCT05849298
What this trial is testing

A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC

Who this might be right for
Prostatic Neoplasm
Novartis Pharmaceuticals 49
Not applicableLooking for participantsNCT06353321
What this trial is testing

Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center 25
Not applicableUnknownNCT04773821
What this trial is testing

Performance of Prostate MRI and Following Biopsy to Detect Prostate Cancer Recurrence After Focal Therapy

Who this might be right for
Prostate Cancer
Assistance Publique - Hôpitaux de Paris 260
Not applicableTemporarily Not AvailableNCT06033001
What this trial is testing

Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Castration-Resistant Prostatic Cancer
Lantheus Medical Imaging
Testing effectiveness (Phase 2)Ended earlyNCT01483586
What this trial is testing

Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer

Who this might be right for
Prostate Cancer
KangLaiTe USA 90
Not applicableStudy completedNCT01178840
What this trial is testing

Prostate Specific Antigen (PSA) and Acute Failure Modes Study of the PATH Woman's Condom and FC2 Female Condom

Who this might be right for
Birth Control
CONRAD 505
Not applicableLooking for participantsNCT05022914
What this trial is testing

PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE

Who this might be right for
Prostate CancerBiochemical Relapse Fo Malignant Neoplasm of ProstateProstate Adenocarcinoma+1 more
Azienda Ospedaliero-Universitaria Careggi 180
Testing effectiveness (Phase 2)Study completedNCT04936334
What this trial is testing

The Role of 68Ga-PSMA-11 PET (Prostate Specific Membrane Antigen) in Surgery Guidance in Prostate Cancer

Who this might be right for
Prostate Cancer
Clinton Bahler 51
Not applicableStudy completedNCT00523484
What this trial is testing

Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNts

Who this might be right for
Prostate Cancer
AstraZeneca 1,200
Not applicableStudy completedNCT07438184
What this trial is testing

Periodontal Therapy and Genitourinary Inflammation in Patients With Prostatitis and Recurrent Urinary Tract Infections

Who this might be right for
PeriodontitisChronic Prostatitis (CP)Urinary Tract Infections
University of Salamanca 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06894511
What this trial is testing

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 7
Load More Results